The Failure of Torcetrapib
- 1 February 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (2) , 257-260
- https://doi.org/10.1161/01.atv.0000256728.60226.77
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol LevelsJournal of the American College of Cardiology, 2006
- HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayJournal of Clinical Investigation, 2006
- Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin TreatmentCirculation, 2005
- A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderlyJournal of Lipid Research, 2004
- A Mouse Model with Features of Familial Combined HyperlipidemiaScience, 1997
- Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.Journal of Clinical Investigation, 1996
- Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.Journal of Clinical Investigation, 1995
- Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.Journal of Clinical Investigation, 1993
- An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.Journal of Clinical Investigation, 1992
- Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiencyAtherosclerosis, 1991